Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Sentinel lymph node biopsy in clinically node-negative Merkel cell carcinoma: the Westmead Hospital experience.

Jenkins LN, Howle JR, Veness MJ.

ANZ J Surg. 2019 May;89(5):520-523. doi: 10.1111/ans.15228. Epub 2019 Apr 8.

PMID:
30959572
2.

Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients.

Lee JH, Saw RP, Thompson JF, Lo S, Spillane AJ, Shannon KF, Stretch JR, Howle J, Menzies AM, Carlino MS, Kefford RF, Long GV, Scolyer RA, Rizos H.

Ann Oncol. 2019 May 1;30(5):815-822. doi: 10.1093/annonc/mdz075.

3.

Symposium Celebrating Women Surgeons Around the World.

Roman S, Jimenez M, Odubu F, Chereau N, Henne-Bruns D, Yip CH, Howle J, Patti MG.

World J Surg. 2018 Dec;42(12):3825-3840. doi: 10.1007/s00268-018-4712-9. No abstract available.

PMID:
29907901
4.
5.

PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors.

Kakavand H, Rawson RV, Pupo GM, Yang JYH, Menzies AM, Carlino MS, Kefford RF, Howle JR, Saw RPM, Thompson JF, Wilmott JS, Long GV, Scolyer RA, Rizos H.

Clin Cancer Res. 2017 Oct 15;23(20):6054-6061. doi: 10.1158/1078-0432.CCR-16-1688. Epub 2017 Jul 19.

6.

Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma.

Vilain RE, Menzies AM, Wilmott JS, Kakavand H, Madore J, Guminski A, Liniker E, Kong BY, Cooper AJ, Howle JR, Saw RPM, Jakrot V, Lo S, Thompson JF, Carlino MS, Kefford RF, Long GV, Scolyer RA.

Clin Cancer Res. 2017 Sep 1;23(17):5024-5033. doi: 10.1158/1078-0432.CCR-16-0698. Epub 2017 May 16.

7.

Definitive radiotherapy for Merkel cell carcinoma confers clinically meaningful in-field locoregional control: A review and analysis of the literature.

Gunaratne DA, Howle JR, Veness MJ.

J Am Acad Dermatol. 2017 Jul;77(1):142-148.e1. doi: 10.1016/j.jaad.2017.02.015. Epub 2017 May 9. Review.

PMID:
28495499
8.

Sentinel node biopsy in patients with intermediate and thick melanomas – A balanced view.

Saw R, Allan C, Barbour A, Ch'ng S, Coventry BJ, Gyorki D, Henderson M, Howle J, Hughes TM, Lee K, Neuhaus S, Saunders C, Shannon K, Smithers M, Speakman D, Spillane J, Stretch J.

Aust Fam Physician. 2015 Dec;44(12):876. No abstract available.

PMID:
27505913
9.

The value of sentinel lymph node biopsy in Merkel cell carcinoma: reply from the authors.

Gunaratne DA, Howle JR, Veness MJ.

Br J Dermatol. 2016 Sep;175(3):650. doi: 10.1111/bjd.14792. Epub 2016 Jul 31. No abstract available.

PMID:
27476497
10.

Sentinel lymph node biopsy in Merkel cell carcinoma: a 15-year institutional experience and statistical analysis of 721 reported cases.

Gunaratne DA, Howle JR, Veness MJ.

Br J Dermatol. 2016 Feb;174(2):273-81. doi: 10.1111/bjd.14240. Epub 2015 Dec 19. Review.

PMID:
26480031
12.

Merkel cell carcinoma: A case of palliative upper limb amputation in a patient with refractory in-transit metastases.

Gunaratne DA, Howle JR, Veness MJ.

Australas J Dermatol. 2016 May;57(2):e53-6. doi: 10.1111/ajd.12291. Epub 2015 Mar 5.

PMID:
25754425
13.

Effect of surgical experience on the macroscopic diagnosis of appendicitis: a retrospective cohort study.

Pham H, Devadas M, Howle J.

Int J Surg. 2015 Apr;16(Pt A):78-82. doi: 10.1016/j.ijsu.2015.02.019. Epub 2015 Mar 6.

14.

Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma.

Long GV, Fung C, Menzies AM, Pupo GM, Carlino MS, Hyman J, Shahheydari H, Tembe V, Thompson JF, Saw RP, Howle J, Hayward NK, Johansson P, Scolyer RA, Kefford RF, Rizos H.

Nat Commun. 2014 Dec 2;5:5694. doi: 10.1038/ncomms6694.

PMID:
25452114
15.

Radiotherapy alone in patients with Merkel cell carcinoma: the Westmead Hospital experience of 41 patients.

Veness M, Howle J.

Australas J Dermatol. 2015 Feb;56(1):19-24. doi: 10.1111/ajd.12263. Epub 2014 Nov 4.

PMID:
25369110
16.

Inaugural Murray F. Brennan, MD, FACS, International Guest Scholar provides report.

Howle J.

Bull Am Coll Surg. 2014 Jul;99(7):70-4. No abstract available.

PMID:
25076749
17.

BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact.

Rizos H, Menzies AM, Pupo GM, Carlino MS, Fung C, Hyman J, Haydu LE, Mijatov B, Becker TM, Boyd SC, Howle J, Saw R, Thompson JF, Kefford RF, Scolyer RA, Long GV.

Clin Cancer Res. 2014 Apr 1;20(7):1965-77. doi: 10.1158/1078-0432.CCR-13-3122. Epub 2014 Jan 24.

18.

Outcome of patients with microscopic and macroscopic metastatic nodal Merkel cell carcinoma: an Australian experience.

Howle JR, Veness MJ.

Dermatol Surg. 2014 Jan;40(1):46-51. doi: 10.1111/dsu.12390. Epub 2013 Dec 10.

PMID:
24320201
19.

Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progression.

Long GV, Wilmott JS, Haydu LE, Tembe V, Sharma R, Rizos H, Thompson JF, Howle J, Scolyer RA, Kefford RF.

Pigment Cell Melanoma Res. 2013 Jul;26(4):499-508. doi: 10.1111/pcmr.12098. Epub 2013 May 3.

PMID:
23557327
20.

Intravascular metastatic melanoma: a difficult diagnosis.

Ghattas S, Howle J, Wang W, Kefford R, Gruenewald S.

Australas J Dermatol. 2013 May;54(2):141-3. doi: 10.1111/ajd.12033. Epub 2013 Feb 21.

PMID:
23425235
21.

Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicine.

Wilmott JS, Tembe V, Howle JR, Sharma R, Thompson JF, Rizos H, Lo RS, Kefford RF, Scolyer RA, Long GV.

Mol Cancer Ther. 2012 Dec;11(12):2704-8. doi: 10.1158/1535-7163.MCT-12-0530. Epub 2012 Sep 7.

22.

Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma.

Menzies AM, Haydu LE, Visintin L, Carlino MS, Howle JR, Thompson JF, Kefford RF, Scolyer RA, Long GV.

Clin Cancer Res. 2012 Jun 15;18(12):3242-9. doi: 10.1158/1078-0432.CCR-12-0052. Epub 2012 Apr 24.

23.

Plexiform fibrohistiocytic tumour: morphological changes and challenges in assessment of recurrent and metastatic lesions.

Lynnhtun K, Achan A, Shingde M, Chou S, Howle JR, Sharma R.

Histopathology. 2012 Jun;60(7):1156-8. doi: 10.1111/j.1365-2559.2011.04173.x. Epub 2012 Mar 21. No abstract available.

PMID:
22435737
24.

Sentinel lymph node biopsy in patients with Merkel cell carcinoma: an emerging role and the Westmead hospital experience.

Howle J, Veness M.

Australas J Dermatol. 2012 Feb;53(1):26-31. doi: 10.1111/j.1440-0960.2011.00838.x.

PMID:
22309327
25.

Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma.

Wilmott JS, Long GV, Howle JR, Haydu LE, Sharma RN, Thompson JF, Kefford RF, Hersey P, Scolyer RA.

Clin Cancer Res. 2012 Mar 1;18(5):1386-94. doi: 10.1158/1078-0432.CCR-11-2479. Epub 2011 Dec 12.

26.

Merkel cell carcinoma metastatic to the transverse colon: disease free after six years - cure or just prolonged remission?

Veness MJ, Howle JR.

Australas J Dermatol. 2011 Nov;52(4):295-7. doi: 10.1111/j.1440-0960.2011.00782.x. Epub 2011 Jun 13.

PMID:
22070707
27.

Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients.

Howle JR, Hughes TM, Gebski V, Veness MJ.

J Am Acad Dermatol. 2012 Jul;67(1):33-40. doi: 10.1016/j.jaad.2011.07.029. Epub 2011 Oct 11.

PMID:
21996296
28.

Patients with clinically node negative extremity Merkel cell carcinoma: The importance of identifying and treating patients with microscopic nodal metastases.

Veness M, Howle J.

Australas J Dermatol. 2010 Nov;51(4):274-8. doi: 10.1111/j.1440-0960.2010.00702.x. Epub 2010 Oct 13.

PMID:
21198525
29.

Fine-needle aspiration cytology features of a recurring plexiform fibrohistiocytic tumor in the upper limb and review of the literature.

Chou S, Howle J, Chandraratnam E, Achan A.

Diagn Cytopathol. 2011 Jan;39(1):49-53. doi: 10.1002/dc.21371. Review.

PMID:
21064216
30.

Managing patients with cutaneous squamous cell carcinoma metastatic to the axilla or groin lymph nodes.

Goh A, Howle J, Hughes M, Veness MJ.

Australas J Dermatol. 2010 May;51(2):113-7. doi: 10.1111/j.1440-0960.2009.00576.x.

PMID:
20546217
31.

Metastatic cutaneous squamous cell carcinoma of the scalp.

Howle JR, Morgan GJ, Kalnins I, Palme CE, Veness MJ.

ANZ J Surg. 2008 Jun;78(6):449-53. doi: 10.1111/j.1445-2197.2008.04533.x.

PMID:
18522564
32.

We need an anchor.

Howle JM.

Pediatr Phys Ther. 2008 Summer;20(2):203. doi: 10.1097/PEP.0b013e3181761ebf. No abstract available.

PMID:
18480722
33.

A proposed mode of action of antitumor platinum compounds based upon studies with cis-dichloro-((G- 3 H)dipyridine)platinum(II).

Howle JA, Gale GR, Smith AB.

Biochem Pharmacol. 1972 May 15;21(10):1465-75. No abstract available.

PMID:
5029426
34.

Cis-dichlorodiammineplatinum [II]: inhibition of nucleic acid synthesis in lymphocytes stimulated with phytohemagglutinin.

Howle JA, Thompson HS, Stone AE, Gale GR.

Proc Soc Exp Biol Med. 1971 Jul;137(3):820-5. No abstract available.

PMID:
4934704
35.

Antitumor and antimitogenic properties of cis-dichloro(dipyridine)platinum(II).

Gale GR, Howle JA, Walker EM Jr.

Cancer Res. 1971 Jul;31(7):950-2. No abstract available.

36.

Chemical and bacteriological studies of the photochemical reaction product of ammonium hexachloroiridate. IV.

Gale GR, Howle JA, Smith AB.

Proc Soc Exp Biol Med. 1970 Dec;135(3):690-4. No abstract available.

PMID:
4922353
37.

Cis-dichlorodiammineplatinum (II). Persistent and selective inhibition of deoxyribonucleic acid synthesis in vivo.

Howle JA, Gale GR.

Biochem Pharmacol. 1970 Oct;19(10):2757-62. No abstract available.

PMID:
5478584
38.
39.

Effects of certain hydroxamic acids on L-glutamate 1-carboxy-lyase.

Howle JA, Gale GR.

Proc Soc Exp Biol Med. 1969 Jul;131(3):697-702. No abstract available.

PMID:
4893114
40.

Effects of pH and bicarbonate content of serum in reducing methylene blue.

CLINE JK, HOWLE J, REID J, JOHNSON L.

Public Health Monogr. 1953;12:9-11. No abstract available.

PMID:
13100565

Supplemental Content

Support Center